Tagged with IP,

Pharma The Vice-Chairman of the Public Health Enhancement Fund talks about how the shortage of medical doctors and the fight against TB, HIV and AIDS in South Africa led the health Minister and the private health sector to create a public health enhancement fund and how the private sector is pulling resources…

Puerto Rico PharmaBoardroom spoke to Osvaldo Caro, President, Chairman and CEO of ReComS, about the legal side of the pharmaceuticals sector in Puerto Rico. What are ReComS’ defining characteristics? ReComS is the only company in Puerto Rico that provides consulting services through a combination of attorneys and other professionals. Our staff is divided…

legal A founding partner of YükselKarkınKüçük, Gökhan Gökçe discusses the firm’s involvement with several high profile cases concerning the healthcare and life science sector’s reference pricing system, and also elaborates on the strategic trends in different types of operating structures as a result of shifting dynamics faced by the broader Turkish…

Doing business The current negotiations for the Trans-Pacific Partnership (TPP) provide Mexico with a not-to-be-missed opportunity to review the country’s intellectual property system. The partner of the life science practice of the most important IP law firm in Mexico discusses the challenges clients from the sector face in the market place and…

IP Alicia Alvarez Berkenwald, Partner at the specialized intellectual property services firm Berken IP, gives an introduction to the Argentinian IP environment, common strategies used to bypass obstacles, and Berken IP’s role in helping increase IP awareness in Argentinian research institutions.   Could you give us an overview of the changes…

entrepreneurship Mauro Bono discusses the challenges of building a company from the interior of Argentina, and shares his assessment of the key issues driving and preventing change in the country’s pharmaceutical sector.   What are some of the challenges and opportunities associated with building a business in Cordoba, given that Argentina’s…

biotech The founder of this spin-off of the Autonomous University of the State of Morelos focusing on biologicals for human and veterinary use offers an overview of how the company came into life, the lack of culture at Mexican universities of filing patents for academic research and the potential of the…

drug development BIOTECanada is the national trade association for Canada’s biotech industry. Andrew Casey, the group’s CEO, discusses the impact of IP regulation on emerging biotech companies, incentives for developing the sector on a national level, and offers perspectives on tax policy and its impact on drug development. How does BIOTECanada actively…